How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
It's an upgrade worth making, but it comes down to your privacy concerns.
The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be ...
What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...
As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...
In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...
Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...
While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...
New VentureBeat survey data: 85% of enterprises run contested AI platforms with no single owner, and only 10% can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results